Description

Francart et al developed models for predicting progression-free and overall survival for patients with malignant mesothelioma enrolled in EORTC trials. The authors are from multiple institutions in Europe and Egypt.


 

Patient selection: ECOG performance status 0 to 2

 

Outcomes:

(1) progression-free survival (PFS)

(2) overall survival (OS)

 

Parameters:

(1) epithelial component in histology

(2) stage

(3) ECOG performance stage

 

Parameter

Finding

Points for PFS

Points for OS

epithelial component

yes

0

0

 

no

42

44

stage

Stage 1 to 3

0

0

 

Stage 4

37

38

ECOG performance

0

0

0

 

1

50

50

 

2

100

100

 

total score for PFS =

= SUM(points for all 3 parameters)

 

total score for OS =

= SUM(points for all 3 parameters)

 

Interpretation:

• minimum scores: 0

• maximum score for PFS: 179

• maximum score for OS: 182

 

probability of 6 month progression-free survival in percent =

= (0.000583 * ((PFS points)^2)) - (0.3141 * (PFS points)) + 40.3

 

probability of 6 month overall survival in percent =

= (-0.000662 * ((OS points)^2)) - (0.2001 * (OS points)) + 82.57

 


To read more or access our algorithms and calculators, please log in or register.